Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name PANDAR
   Synonyms PANDAR, PANDA
   Region GRCh38_6:36673621-36675126    Sequence
   Ensembl ENSG00000281450
   RefSeq NR_109836
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name cervical cancer
   ICD-0-3 C53  
   Methods qPCR etc.
   Sample cervical squamous tissues, cell lines (HeLa, C33-A)
   Expression Pattern up-regulated
   Function Description

The results of qRT-PCR showed that the expression level of PANDAR was signifcantly up-regulated in cervical cancer tissues compared with that in cancer-adjacent tissues. Statistical analysis showed that PANDAR expression was correlated with International Federation of Gynecology and Obstetrics (FIGO) staging, tumor size and tumor invasion degree. Kaplan-Meier survival analysis showed that the survival time of patients with highly expressed PANDAR was shorter than that of patients with lowly expressed PANDAR. Cox multivariate regression analysis showed that PANDAR could be used as an independent prognostic factor for patients with cervical cancer. CCK-8 results showed that interference in PANDAR signifcantly inhibited tumor cell proliferation.

   Pubmed ID 29131264
   Year 2017
   Title Upregulation of LncRNA PANDAR predicts poor prognosis and promotes cell proliferation in cervical cancer
   External Links
   Links for  PANDAR GenBank       HGNC       lncrnadb       Noncode
   Links for  cervical cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.